As the new 116^th Congress gets underway, four House and Senate committees are holding hearings to examine health policy issues, including two hearings focusing on prescription drug prices.  Specifically, the following hearings are all scheduled for January 29, 2019:

• A Senate Finance Committee hearing on “Drug Pricing in America: A Prescription for Change, Part I,” which will feature testimony from economists, a patient advocate, and others.
• A House Committee on Oversight and Reform hearing entitled “Examining the Actions of Drug Companies in Raising Prescription Drug Prices,” which follows earlier letters the panel sent to pharmaceutical companies regarding drug pricing practices.
• A House Ways and Means Committee hearing on “Protecting Americans with Pre-Existing Conditions.”
• A Senate Health, Education, Labor and Pensions Committee hearing on “Access to Care: Health Centers and Providers in Underserved Communities.”